Why is Genomic Valley falling/rising?

As of 05-Jun, Genomic Valley Biotech Ltd's stock price is currently at Rs 48.00, reflecting an increase of Rs 1.75 or 3.78%. The stock has been gaining for the last two days, with a total return of 6.69% during this period. Today's performance indicates that it has outperformed its sector by 3.94%. Despite this positive movement, the stock has experienced a significant decline of 20.27% over the past month and a year-to-date drop of 39.24%. The stock's performance is currently higher than its 5-day moving averages but remains lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a rise in investor participation, with delivery volume increasing by 3.24% against the 5-day average.
In the broader market context, the Sensex has shown a slight decline of 0.23% over the past week, while Genomic Valley's stock has remained flat in that same timeframe. This indicates that the stock's recent gains are somewhat isolated from the overall market trend. Year-to-date, while the Sensex has increased by 4.23%, Genomic Valley's substantial decline highlights its underperformance relative to the benchmark. The lack of specific positive or negative factors in the dashboard makes it difficult to pinpoint additional influences on the stock's recent movement, but the rising investor participation suggests a potential recovery interest among traders.